Clinical trials · Chicago, IL
Metastatic Head and Neck Squamous Cell Carcinoma clinical trials in Chicago
We’re tracking 30 recruiting metastatic head and neck squamous cell carcinoma studies with a site in or near Chicago — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Chicago
- NCT05526924RecruitingPhase 1
Phase 1 trial tests re-radiation plus immunotherapy and a cancer pill
This trial studies whether adding a checkpoint immunotherapy (tislelizumab) and a cancer pill (pamiparib) to radiation can better treat cancer that has come back in the head and neck. It’s for adults with previously treated, HPV-positive oropharynx tumors, usually without widespread spread.
Chicago, IllinoisAges 18 years+ - NCT05136196RecruitingPhase 2
Cabozantinib plus nivolumab for advanced melanoma or head-neck cancer
This trial tests whether combining two immunotherapy medicines—cabozantinib and nivolumab—can shrink advanced melanoma or certain head-and-neck squamous cell cancers. It is mainly for people whose cancer has grown after prior PD-1 treatment.
Chicago, IllinoisAges 18 years+ - NCT05005403RecruitingPhase 1
Testing azirkitug for lung, head/neck, and other solid cancers
This Phase 1 study tests how a new medicine (azirkitug) behaves in the body and how safe it is, given by IV infusion alone or with other cancer drugs. It may help people with several advanced solid tumor cancers, especially after standard treatments have stopped working.
Chicago, IllinoisAges 18 years+ - NCT06769698RecruitingPhase 2
Testing fianlimab with cemiplimab for head and neck cancer
This study compares a new combination of two drugs (fianlimab and cemiplimab) against cemiplimab alone for people with head and neck cancer that has returned or spread. It aims to see if the combination works better.
Evanston, IllinoisAges 18 years+ - NCT06129864RecruitingPhase 3
Study of Volrustomig for advanced head and neck cancer after chemoradiation
This trial tests a new drug called volrustomig (MEDI5752) for people with advanced head and neck cancer that was not removed by surgery and has been treated with chemoradiation. The goal is to see if the drug can help prevent the cancer from coming back.
Niles, IllinoisAges 18–130 - NCT05635643RecruitingPhase 1
Immunotherapy trial for advanced solid tumors and head/neck cancer
This Phase 1 study tests CHS-114, a medicine designed to help the immune system fight advanced cancers. It is for adults whose cancer has continued growing or returned after standard treatments, and it checks safety and early signs of benefit.
Hinsdale, IllinoisAges 18 years+
Hear when a new Metastatic Head and Neck Squamous Cell Carcinoma trial opens near Chicago, IL
We’ll email you when one opens near Chicago, IL — at most once a week, no account needed, unsubscribe anytime.
Metastatic Head and Neck Squamous Cell Carcinoma trials in other cities
Where these studies are running near Chicago
Institutions with a site for the recruiting metastatic head and neck squamous cell carcinoma studies listed above.
- Northwestern University · 2 studies
- University of Chicago · 2 studies
- University of Illinois · 2 studies
- Loyola University Medical Center
- Northwestern Medicine Cancer Center Delnor
- Northwestern Medicine Cancer Center Warrenville
- Northwestern Medicine Glenview Outpatient Center
- Northwestern Medicine Grayslake Outpatient Center
What taking part in a metastatic head and neck squamous cell carcinoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting metastatic head and neck squamous cell carcinoma studies in Illinois.
Common questions
- Are there metastatic head and neck squamous cell carcinoma clinical trials near Chicago?
- Yes. We're currently tracking 30 recruiting metastatic head and neck squamous cell carcinoma studies with a site near Chicago, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a metastatic head and neck squamous cell carcinoma study near Chicago?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Chicago to take part?
- Not necessarily. These studies have a site near Chicago, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a metastatic head and neck squamous cell carcinoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New metastatic head and neck squamous cell carcinoma studies open near Chicago regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.